Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q2 EPS of ($0.15), $0.04 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.